Steven C. Ebert

2.5k total citations · 1 hit paper
28 papers, 2.0k citations indexed

About

Steven C. Ebert is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Steven C. Ebert has authored 28 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 10 papers in Epidemiology and 10 papers in Molecular Medicine. Recurrent topics in Steven C. Ebert's work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Antibiotic Resistance in Bacteria (10 papers) and Antibiotic Use and Resistance (8 papers). Steven C. Ebert is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (19 papers), Antibiotic Resistance in Bacteria (10 papers) and Antibiotic Use and Resistance (8 papers). Steven C. Ebert collaborates with scholars based in United States. Steven C. Ebert's co-authors include William A. Craig, J. E. Leggett, Bennett Vogelman, Sigurður Guðmundsson, John Turnidge, B. Fantin, W. A. Craig, Wim Calame, Kyoichi Totsuka and H. Mattie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Steven C. Ebert

25 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model

1988 595 citations Bennett Vogelman, Sigurður Guðmundsson et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven C. Ebert United States	16	1.7k	1.1k	854	362	307	28	2.0k
Bennett Vogelman United States	15	1.5k 0.9×	959 0.9×	684 0.8×	355 1.0×	232 0.8×	25	1.9k
C H Nightingale United States	26	1.2k 0.7×	576 0.5×	962 1.1×	261 0.7×	205 0.7×	70	2.3k
Joseph A. Paladino United States	25	1.2k 0.7×	581 0.5×	965 1.1×	392 1.1×	683 2.2×	78	2.3k
Charles H. Ballow United States	24	1.7k 1.0×	1.2k 1.1×	1.2k 1.5×	675 1.9×	628 2.0×	44	3.1k
J. Blaser Switzerland	21	995 0.6×	654 0.6×	544 0.6×	271 0.7×	154 0.5×	51	1.6k
Christopher M. Rubino United States	24	1.3k 0.8×	807 0.8×	808 0.9×	350 1.0×	264 0.9×	112	2.2k
Fekade B. Sime Australia	24	1.2k 0.7×	731 0.7×	645 0.8×	224 0.6×	417 1.4×	87	1.8k
Frédérique Jacobs Belgium	30	1.8k 1.0×	640 0.6×	1.4k 1.6×	459 1.3×	666 2.2×	72	3.0k
James B. Kahn United States	27	1.4k 0.8×	1.1k 1.0×	1.9k 2.2×	290 0.8×	420 1.4×	61	3.0k
Karen E. Bowker United Kingdom	25	888 0.5×	804 0.8×	528 0.6×	270 0.7×	207 0.7×	89	1.9k

Countries citing papers authored by Steven C. Ebert

Since Specialization

Citations

This map shows the geographic impact of Steven C. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven C. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven C. Ebert more than expected).

Fields of papers citing papers by Steven C. Ebert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven C. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven C. Ebert. The network helps show where Steven C. Ebert may publish in the future.

Co-authorship network of co-authors of Steven C. Ebert

This figure shows the co-authorship network connecting the top 25 collaborators of Steven C. Ebert. A scholar is included among the top collaborators of Steven C. Ebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven C. Ebert. Steven C. Ebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ebert, Steven C., et al.. (2022). Trends in antibiotic use before and during the coronavirus disease 2019 (COVID-19) pandemic across an integrated health system with different antimicrobial stewardship program models trends in antibiotic use by ASP model. SHILAP Revista de lepidopterología. 2(1). e55–e55. 1 indexed citations

2.

Ebert, Steven C., et al.. (2019). 2066. Development and Implementation of Prescribing Algorithms for Antibiotics on Discharge from the Emergency Department. Open Forum Infectious Diseases. 6(Supplement_2). S696–S696. 1 indexed citations

3.

Ebert, Steven C.. (2007). Factors Contributing to Excessive Antimicrobial Prescribing. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(10P2). 126S–130S. 23 indexed citations

4.

Maki, Dennis G., Nasia Safdar, & Steven C. Ebert. (2007). Prevalence, Consequences, and Solutions. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(10P2). 121S–125S. 4 indexed citations

5.

Ebert, Steven C., et al.. (2006). Prospective evaluation of the treatment and outcome of community-acquired pneumonia according to the Pneumonia Severity Index in VHA hospitals. Diagnostic Microbiology and Infectious Disease. 54(4). 267–275. 8 indexed citations

6.

Ebert, Steven C.. (1992). Characterization of the postantibiotic effect.. PubMed. 11(10). 876–7.

7.

Fantin, B., Steven C. Ebert, J. E. Leggett, Bennett Vogelman, & William A. Craig. (1991). Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against Gram-negative bacilli. Journal of Antimicrobial Chemotherapy. 27(6). 829–836. 66 indexed citations

8.

Craig, W. A., et al.. (1991). Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. Journal of Antimicrobial Chemotherapy. 27(suppl C). 29–40. 192 indexed citations

9.

Ebert, Steven C., et al.. (1991). Role of Antimicrobial Pharmacokinetics and Pharmacodynamics in Surgical Prophylaxis. Clinical Infectious Diseases. 13(Supplement_10). S790–S799. 41 indexed citations

10.

Leggett, J. E., Steven C. Ebert, B. Fantin, & W. A. Craig. (1990). Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models.. PubMed. 74. 179–84. 109 indexed citations

11.

Ebert, Steven C. & William A. Craig. (1990). Pharmacodynamic Properties of Antibiotics: Application to Drug Monitoring and Dosage Regimen Design. Infection Control and Hospital Epidemiology. 11(6). 319–326. 27 indexed citations

12.

Ebert, Steven C. & William A. Craig. (1990). Pharmacodynamic Properties of Antibiotics: Application to Drug Monitoring and Dosage Regimen Design. Infection Control and Hospital Epidemiology. 11(6). 319–326. 61 indexed citations

13.

Ebert, Steven C., et al.. (1989). Comparison of Aminoglycoside Concentrations Measured in Plasma Versus Serum. Therapeutic Drug Monitoring. 11(1). 44–46. 4 indexed citations

14.

Leggett, J. E., B. Fantin, Steven C. Ebert, et al.. (1989). Comparative Antibiotic Dose-Effect Relations at Several Dosing Intervals in Murine Pneumonitis and Thigh-Infection Models. The Journal of Infectious Diseases. 159(2). 281–292. 298 indexed citations

15.

Ebert, Steven C., et al.. (1989). Penetration of antibiotics into the surgical wound in a canine model. Antimicrobial Agents and Chemotherapy. 33(5). 700–704. 17 indexed citations

16.

Craig, William A. & Steven C. Ebert. (1989). Protein Binding and Its Significance in Antibacterial Therapy. Infectious Disease Clinics of North America. 3(3). 407–414. 62 indexed citations

17.

Vogelman, Bennett, Sigurður Guðmundsson, J. E. Leggett, et al.. (1988). Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model. The Journal of Infectious Diseases. 158(4). 831–847. 595 indexed citations breakdown →

18.

Ebert, Steven C., J. E. Leggett, Bennett Vogelman, & William A. Craig. (1988). Evidence for a Slow Elimination Phase for Penicillin G. The Journal of Infectious Diseases. 158(1). 200–202. 21 indexed citations

19.

Golenbock, D T, Steven C. Ebert, J. A. Will, & Richard A. Proctor. (1988). Elimination and tissue distribution of the monosaccharide lipid A precursor, lipid X, in mice and sheep. Antimicrobial Agents and Chemotherapy. 32(1). 37–41. 3 indexed citations

20.

Gasser, Thomas C., et al.. (1987). Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function. Antimicrobial Agents and Chemotherapy. 31(5). 709–712. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact